Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC

A patient with a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic non-small cell lung cancer (NSCLC) experienced a multisite radiological progression at 3 months after initiation of chemoimmunotherapy as first-line treatment for metastatic disease. After the radiological progression, while...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Nicolas Roussot, Marion Thibaudin, Jean-David Fumet, Susy Daumoine, Léa Hampe, Cédric Rébé, Emeric Limagne, Aurélie Lagrange, Victor Herreros, Julie Lecuelle, Hugo Mananet, Alis Ilie, David Rageot, Romain Boidot, Vincent Goussot, Anthony Comte, Pierre Jacob, Françoise Beltjens, Anthony Bergeron, Céline Charon-Barra, Laurent Arnould, Valentin Derangère, Sylvain Ladoire, Caroline Truntzer, François Ghiringhelli
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2024-08-01
Serija:	Frontiers in Immunology
Teme:	case report NSCLC pseudoprogression chemoimmunotherapy neoantigen cold tumor
Online dostop:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1437961/full
Oznake:	Označite Brez oznak, prvi označite!